Hledání článků
Filtry
Gupta R, Plantinga LC, Fink NE, et al. Statin use and hospitalization for sepsis in patients with chronic kidney disease. J Am Med Assoc 2007;297:1455–1464.
Löwik MM, Groenen PJTA, Pronk I, et al. Focal segmental glomerulosclerosis in a patient homozygous for a C D2A P mutation. Kidney Int 2007;72: 1198–1203.
Dooley AC, Weiss NS, Kestenbaum B. Increased risk of hip fracture among men with CKD. Am J Kidney Dis 2008 Jan;51(1):38–44.
Fan SL, Pile T, Punzalan S, Raftery MJ, Yaqoob MM. Randomized controlled study of biocompatible peritoneal dialysis solutions: effect on residual renal function. Kidney Int 2008;73:200–206.
Silva Jr HT, Yang HC, Abouljound M, et al. One‑year results with extended‑release tacrolimus/MMF, tacrolimus/MMF and cyclosporine/MMF in de novo kidney transplant recipients. Am J Transplant 2007;7:595–608.
Ekberg H, Tedesco‑Silva H, Demirbas A, Vítko S, Nashan B, Gürkan A, Margreiter R, Hugo C, Grinyó JM, Frei U, Vanrenterghem Y, Daloze P, Halloran PF, for the ELITE–Symphony Study. Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation. N Eng J Med 2007;357:2562–2575.
Dong J, Li Y‑J, Lu X‑h, Gan H‑p, Zuo L, Wang H‑y. Correlations of lean body mass with nutritional indicators and mortality in patients on peritoneal dialysis. Kidney Int 2008,73:334–340.
Wang Y, Chen X, Song Y, Caballero B, Cheskin LJ. Association between obesity and kidney disease: a systematic review and meta‑analysis. Kidney Int 2008,73: 19–33.
Moist LM, Bragg.Gresham JL, Pisoni RL, Saran R, Akiba T, Jacobson SH, Fukuhara S, Mapes DL, Rayner HC, Saito A, Port FK. Travel time to dialysis as a predictor of health.related quality of life, adherence, and mortality: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2008; 51:641.650.
Williams ME, Kline Bolton W, Khalifah RG, et al. Effects of pyridoxamine in combined phase 2 studies of patients with type 1 and type 2 diabetes and overt nephropathy. Am J Nephrol 2007;27:605–614.
Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008;358:1887–1998.
Kliem V, Fricke L, Wollbrink T, Burg M, Radermacher J, Rohde F. Improvement in long‑term renal graft survival due to CMV prophylaxis with oral ganciclovir: results of a randomized clinical trial. Am J Transplant 2008;8:975–983.